Article info
PDFHepatitis
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Dr T Asselah, Service d’Hépatologie and INSERM CRB3, Beaujon Hospital, 92 110 Clichy, France; tarik.asselah{at}bjn.aphp.fr
Citation
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
Publication history
- Revised August 3, 2007
- Accepted August 28, 2007
- First published September 25, 2007.
Online issue publication
March 11, 2008
Article Versions
- Previous version (25 September 2007).
- Previous version (28 September 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group & British Society of Gastroenterology